Today: 27 April 2026
Browse Category

Technology 5 January 2026 - 6 January 2026

DroneShield stock jumps 18% as ASX:DRO taps Louis Gamarra as chief commercial officer

DroneShield stock jumps 18% as ASX:DRO taps Louis Gamarra as chief commercial officer

DroneShield shares surged 18.1% to A$3.91 in Sydney on Tuesday, with turnover more than doubling to 32 million shares. The company named Louis Gamarra chief commercial officer to lead global sales. The rally lifted the stock 27% above its Dec. 31 close, even as the broader ASX 200 fell 0.5%. Investors await the next earnings update for signs of sustained demand.
6 January 2026
··
Marvell (MRVL) stock lifts on Melius “buy” call, with CES CEO appearance next

Marvell (MRVL) stock lifts on Melius “buy” call, with CES CEO appearance next

Marvell Technology shares closed up 0.94% at $90.23 after Melius Research upgraded the stock to “buy” with a $135 target. The move follows Marvell’s $3.25 billion deal to acquire Celestial AI and a new warrant allowing Amazon to buy shares tied to future photonic product purchases. The stock traded between $89.84 and $93.83 during the session. CEO Matt Murphy is set to speak at CES on Tuesday.
6 January 2026
··
Nvidia says Rubin chips are in full production at CES 2026 as Mercedes adopts DRIVE AV

Nvidia says Rubin chips are in full production at CES 2026 as Mercedes adopts DRIVE AV

Nvidia CEO Jensen Huang announced at CES that the company’s Vera Rubin AI platform is in full production and delivers five times the AI computing power of previous chips for chatbots and similar tasks. Rubin-based products will be available through partners in the second half of 2026. Nvidia said Rubin can cut inference token costs by up to 10 times and train models with four times fewer GPUs than its Blackwell platform.
6 January 2026
····
Intel stock whipsaws ahead of CES Panther Lake debut as 18A chipmaking bet comes due

Intel stock whipsaws ahead of CES Panther Lake debut as 18A chipmaking bet comes due

Intel closed down 0.03% at $39.37 after a volatile session ahead of its CES update on the Panther Lake chip, the first high-volume product on its 18A process. Melius Research upgraded the stock to “buy” with a $50 target. Shares traded heavily, opening at $41.68 and hitting a low of $39.28 before settling near flat. Investors await details on manufacturing progress at the company’s 6 p.m. ET CES event.
6 January 2026
···
AMD stock slips after the bell ahead of Lisa Su’s CES keynote — what investors are watching

AMD stock slips after the bell ahead of Lisa Su’s CES keynote — what investors are watching

AMD shares fell 1.1% to $221.08 in after-hours trading Monday, ahead of CEO Lisa Su’s CES keynote at 9:30 p.m. ET. Nvidia slipped 0.4% while Intel was little changed. Investors are watching for concrete product timelines in AI PCs and data-center accelerators. AMD’s stock remains about 17% below its 52-week high, despite a 71% gain over the past year.
5 January 2026
···
Broadcom stock drops as chip ETFs rise; traders parse CES AI cues and Friday jobs report

Broadcom stock drops as chip ETFs rise; traders parse CES AI cues and Friday jobs report

Broadcom shares fell 2% to $340.71 Monday, underperforming chip ETFs that closed higher. The stock swung from an early high near $355 to a low around $336. Investors watched CES headlines and weak U.S. factory data for signals on AI demand and rates. Broadcom’s next earnings are due in early March; the U.S. jobs report arrives Friday.
5 January 2026
······
KLA Corporation stock jumps 6% as chip-equipment rally builds ahead of Nvidia CES keynote

KLA Corporation stock jumps 6% as chip-equipment rally builds ahead of Nvidia CES keynote

KLA Corp shares jumped 6.4% to $1,356 Monday, nearing a record close as chip-equipment stocks rallied ahead of CES and Nvidia CEO Jensen Huang’s keynote. The Philadelphia Semiconductor Index rose about 1%. Foxconn reported record Q4 revenue, citing AI demand. KLA last forecast Q2 revenue of about $3.225 billion and warned of risks from U.S. export rules affecting China sales.
5 January 2026
···
Qualcomm stock rises on Google auto AI tie-up, Snapdragon X2 laptop push at CES 2026

Qualcomm stock rises on Google auto AI tie-up, Snapdragon X2 laptop push at CES 2026

Qualcomm shares rose 1.7% to $175.96 Monday after the company and Google expanded their automotive partnership at CES, focusing on long-term software support and “agentic AI.” Qualcomm also unveiled new PC and robotics chips. Investors are watching for further CES design wins and Qualcomm’s Feb. 4 earnings. The Philadelphia Semiconductor Index gained 0.9% in afternoon trading.
5 January 2026
····
Jabil stock slides on Hanley Energy buy: what the $725 million AI data center deal means for JBL

Jabil stock slides on Hanley Energy buy: what the $725 million AI data center deal means for JBL

Jabil shares dropped 7.3% to $222.90 after the company said it completed its $725 million cash acquisition of Hanley Energy Group. The deal, closed Jan. 2, adds 850 employees and expands Jabil’s data center power capabilities. Investors focused on integration risks and cash outlay, as Jabil’s stock fell while the broader market rose. The company’s annual meeting is set for January 22.
5 January 2026
···
Western Digital (WDC) stock whipsaws as AI memory crunch drives storage trade

Western Digital (WDC) stock whipsaws as AI memory crunch drives storage trade

Western Digital shares fell 0.9% to $186.00 Monday afternoon after rising as much as 4.3% earlier, as investors shifted positions in storage and memory stocks tied to AI infrastructure. A Reuters report cited a global supply crunch in high-bandwidth memory, with some prices doubling since last year. Sandisk rose 1.5%, while Seagate and Applied Digital gained over 3%. Western Digital’s next earnings report is expected February 4.
5 January 2026
···
Marvell stock (MRVL) rises after Melius upgrade sets $135 target ahead of CES CEO chat

Marvell stock (MRVL) rises after Melius upgrade sets $135 target ahead of CES CEO chat

Marvell Technology shares rose 1.5% to $90.69 Monday after Melius Research upgraded the stock to “buy” with a $135 target. The move followed Marvell’s $3.25 billion deal for Celestial AI and ahead of CEO Matt Murphy’s scheduled CES appearance Tuesday. The stock opened at $93.08 and remains about 29% below its 52-week high. Investors also await the U.S. December jobs report on Friday.
5 January 2026
··
SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime shares fell nearly 9% to $336.50 Monday afternoon, erasing earlier gains and much of their start-of-year advance. The drop came after the stock surpassed the average analyst target of $355, drawing valuation scrutiny. The move contrasted with a 1.7% gain in the PHLX Semiconductor Index as chip stocks broadly rallied. Investors are watching for SiTime’s next earnings update.
5 January 2026
····
1 … 89 90 91 92 93 … 205

Stock Market Today

  • S&P 500 and Nasdaq Set for Intraday Records Amid Sector Strength and Earnings Focus
    April 27, 2026, 5:02 PM EDT. The S&P 500 and Nasdaq Composite are poised for their 12th and eighth intraday record highs of the year, respectively, driven by strong performances in semiconductors, mega-cap tech, and industrial sectors. Fresh highs emerged in multiple exchange-traded funds (ETFs) including small-cap tech, materials, and sectors like technology and semiconductors. Notable stocks hitting highs span various industries: Casey's in consumer staples; Kirby and Cummins in industrials; Nucor and Linde in materials; and big tech names like Alphabet, Nvidia, Intel, and Taiwan Semiconductor. The momentum continues despite recent concerns over the Strait of Hormuz closure and key May earnings reports. Investors remain focused on the resilience of mega-cap tech and cyclicals, underscoring a broad market advance across sectors and styles.

Latest article

Sagimet Stock Surges as $175 Million Raise Sharpens Acne Drug Push

Sagimet Stock Surges as $175 Million Raise Sharpens Acne Drug Push

27 April 2026
Sagimet Biosciences priced 29.17 million shares at $6 each, seeking to raise $175 million to fund a U.S. Phase 3 acne trial for denifanstat. Shares rose 38% to $8.12 on heavy volume Monday. The company will delay further work on its MASH liver-disease program unless it secures non-dilutive funding. Sagimet reported about $104.5 million in cash and equivalents.
Go toTop